Showing results (101-110 of 1,011) with videos related to
Sort By:
Pageof 102
Vutreshni Bolesti|January 1, 1976
[Quantitative determination of Willebrand factor activity in Willebrand's disease]V Buchvarova, M Samama, C LecrubierArchives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1991
[Heparin in the treatment and secondary prevention of myocardial infarction. A critical review of the main trials]A Kher, M Samama, R HaïatArchives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1991
[Therapeutic indications of low molecular weight heparins]M M Samama, F Michaut-PaternoPathologie-Biologie|June 1, 1989
[Dermatan sulfate and the prevention of experimental venous thrombosis]P Desnoyers, L Bara, M SamamaArchives Des Maladies Du Coeur Et Des Vaisseaux|May 1, 1988
[Actilyse: biological aspects]M Samama, B Cormier, J ConardThrombosis Research|February 15, 1990
In vitro effect on Heptest of low molecular weight heparin fractions and preparations with various anti-IIa and anti-Xa activitiesL Bara, J Mardiguian, M SamamaJournal of Controlled Release : Official Journal of the Controlled Release Society|May 28, 2009
Encapsulation of low molecular weight heparins: influence on the anti-Xa/anti-IIa ratioL Javot, T Lecompte, M Rabiskova, et al.Clinical and Laboratory Haematology|September 24, 2005
Pseudo-storage pool disease due to platelet degranulation in EDTA-collected peripheral blood: a rare artifactJ-F Lesesve, V Latger-Cannard, T LecompteJournal of Immunological Methods|June 9, 1998
Immunopurification of human beta2-glycorprotein I with a monoclonal antibody selected for its binding kinetics using a surface plasmon resonance biosensorV Regnault, J Arvieux, L Vallar, et al.Pageof 102